Savara launches late-stage study of AeroVanc in CF patients with MRSA lung infections Seeking Alpha By John Harbison|2017-09-26T08:09:10-08:00September 26, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara launches late-stage study of AeroVanc in CF patients with MRSA lung infections Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
